A RANDOMIZED PHASE III TRIAL OF ABVD VS STANDFORD V+/- RADIATION HODGKIN'S DIS

ABVD 与 STANDFORD V /- 辐射霍奇金 DIS 的随机 III 期试验

• 批准号: 7625775
• 负责人: Witold B. Rybka
• 金额: $ 1.13万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625775
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Disease; Failure; Funding; Grant; Hodgkin Disease; Institution; Patients; Phase; Radiation; Radiation therapy; Randomized; Research; Research Personnel; Resources; Source; Staging; Standards of Weights and Measures; United States National Institutes of Health; bleomycin/dacarbazine/doxorubicin/vinblastine protocol; chemotherapy

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objective of this trial is to compare the failure-free survival in patients with locally extensive and advanced stage Hodgkin's Disease treated with standard ABVD chemotherapy ¿ radiotherapy Disease.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本试验的目的是比较接受标准ABVD化疗和放疗的局部广泛期和晚期霍奇金病患者的无失败生存期。